ClinicalTrials.Veeva

Menu

Regional Anesthesia for Percutaneous Transluminal Angioplasty

G

Gazi University

Status

Completed

Conditions

Peripheral Artery Occlusive Disease
Percutaneous Transluminal Angioplasty

Treatments

Device: Near Infrared Spectroscopy (NIRS)

Study type

Observational

Funder types

Other

Identifiers

NCT05737225
775 (24.10.2022)

Details and patient eligibility

About

In this study, the effects of regional anesthesia method applied in patients who will undergo percutaneous transluminal angioplasty for lower extremity revascularization will be investigated comparatively.

Enrollment

70 patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age: > 18 years
  • Peripheral artery occlusive disease
  • Eligibility for PTA

Exclusion criteria

  • Patients' refusal
  • Under the age of 18
  • Language problems (not knowing turkish)
  • Psychological or mental disorders.
  • Disturbance of Conscious level.
  • Uncooperative patients
  • Those who are allergic to anesthetic drugs to be used
  • Those with contraindications for the application of peripheral nerve block (coagulopathy, skin infection at the block site)
  • need for endotracheal intubation or general anesthesia

Trial design

70 participants in 2 patient groups

Popliteal sciatic nerve block group
Description:
regional anesthesia applied patients who will undergo percutaneous transluminal angioplasty (PTA) procedure
Treatment:
Device: Near Infrared Spectroscopy (NIRS)
Control group
Description:
patients who will undergo percutaneous transluminal angioplasty (PTA) procedure
Treatment:
Device: Near Infrared Spectroscopy (NIRS)

Trial contacts and locations

1

Loading...

Central trial contact

Demet Çoşkun, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems